Table 2.
Summary of the therapeutic drugs that target glial cells.
Neuropsychiatric disorder | Glial cells affected | Therapeutics targeting glial cells | Glial cells responsive to therapeutics |
---|---|---|---|
Major depressive disorder | Astrocytes | Riluzole (Yoshizumi et al., 2012) | -Astrocytes |
Microglia | Fluoxetine, Paroxetine (Allaman et al., 2011) | -Oligodendrocyte | |
Oligodendrocytes | Ceftriaxone (Li et al., 2012) | progenitors | |
Minocycline (Hinwood et al., 2012) | -Microglia | ||
Bipolar disorder | Oligodendrocytes | Lithium (Orre et al., 2009; Souza Ade et al., 2010) | -Astrocytes |
Astrocytes | -Oligodendrocyte | ||
Microglia | progenitors | ||
Anxiety disorders | Oligodendrocytes | Riluzole (Pittenger et al., 2008) | -Astrocytes |
Astrocytes | Benzodiazepines (Patte et al., 1999) | ||
Schizophrenia | Astrocytes | Minocycline (Chaudhry et al., 2012) | -Microglia |
Microglia | Risperidone (Kato et al., 2007) | ||
Oligodendrocytes | Chlorpromazine and loxapine (Labuzek et al., 2005) | ||
Substance use disorders | Astrocytes | Ibudilast, AV1013, minocycline (Snider et al., 2013) | -Microglia |
Microglia | |||
Oligodendrocytes | |||
Alexander disease | Astrocytes |